Skip to main content
Caplight Logo









Shanghai Ligatech Bioscience Co., Ltd.

Shanghai Ligatech Bioscience Co., Ltd.

Private
ShanghaiHealthcare & Life Scienceshttps://ligatech.com.cn

Last Round

Series D

Sep 21, 2023

Est. Valuation

$71.25M

Total Funding Raised

$42.35M

Company Overview

Shanghai Ligatech Bioscience Co., Ltd. is a medical device company that specializes in the research, development, production, and commercialization of orthopedic sports medicine products, biomedical materials, and digital orthopedic imaging solutions.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Medical AI, Sports & Fitness

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

sports medicineorthopedic implantsorthopedic surgeryarthroscopyorthopedic imagingmedical devicessurgical instrumentsligament reconstructionsuture anchorsortho-techAI diagnosticsclinical decision supportdigital orthopedicsmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Shanghai Ligatech Bioscience Co., Ltd. Comparables

Compare Shanghai Ligatech Bioscience Co., Ltd. with similar companies based on industry and business-model similarity.

Shanghai Ligatech Bioscience Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Star Sports Medicine Co Ltd
86%
Beijing Delta Medical Science & Technology Corporation Ltd.
86%
Well Trust (Tianjin) Tech. Co., Ltd.
80%

Shanghai Ligatech Bioscience Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series DSep 21, 2023
StrategicDec 23, 2022
Series CJul 15, 2021
Series BNov 23, 2020
Series AJul 23, 2019
Series A
Nov 1, 2017

Shanghai Ligatech Bioscience Co., Ltd. Investors

Notable investors and investment history

Shanghai Ligatech Bioscience Co., Ltd. investors
InvestorRounds
Sunland FundSeries A
Boyuan CapitalSeries C
Bencao CapitalSeries A, Series C
Legend CapitalSeries D, Series A
Chunyuan CapitalSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 21, 2023

    $26M round with participation from Legend Capital.

  • Sep 1, 2023

    Grew 150% QoQ, from 2 to 5 employees.

Shanghai Ligatech Bioscience Co., Ltd. Filings

Explore SEC and related filing metadata, where available.

Shanghai Ligatech Bioscience Co., Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Shanghai Ligatech Bioscience Co., Ltd.'s valuation, stock price, and market status.

Is Shanghai Ligatech Bioscience Co., Ltd. a public or private company?

Shanghai Ligatech Bioscience Co., Ltd. is a private company.

What is the current stock price of Shanghai Ligatech Bioscience Co., Ltd.?

Shanghai Ligatech Bioscience Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Shanghai Ligatech Bioscience Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Shanghai Ligatech Bioscience Co., Ltd. worth (valuation)?

Shanghai Ligatech Bioscience Co., Ltd.'s valuation is estimated at $71.3M based on funding round data.

Can I buy Shanghai Ligatech Bioscience Co., Ltd. stock?

Shanghai Ligatech Bioscience Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Shanghai Ligatech Bioscience Co., Ltd.'s last funding round?

Shanghai Ligatech Bioscience Co., Ltd.'s most recent funding round was Series D on September 21, 2023.

Who are the main investors in Shanghai Ligatech Bioscience Co., Ltd.?

Key investors in Shanghai Ligatech Bioscience Co., Ltd. include Legend Capital.

Will Shanghai Ligatech Bioscience Co., Ltd. IPO soon?

No public IPO plans have been announced for Shanghai Ligatech Bioscience Co., Ltd..

How can I track Shanghai Ligatech Bioscience Co., Ltd. secondary market activity?

Caplight tracks bids, offers, and trades in Shanghai Ligatech Bioscience Co., Ltd.'s shares on secondary markets.

Firmographic Details

HeadquartersShanghai
Employee Range4
Year Founded2014
Last FundingSep 21, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?